Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Open accessThe DOI matches its Crossref record; 264 of the 275 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the clinical and cost-effectiveness of vitamin K in preventing osteoporotic fractures in postmenopausal women. DATA SOURCES: Searches were conducted in May 2007 in MEDLINE, MEDLINE In-Process, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Controlled Trials Register, BIOSIS, CINAHL, DARE, NHS EED and HTA databases, AMED, NRR, Science Citation Index and Current Controlled Trials. The MEDLINE search was updated in March 2009. REVIEW METHODS: Selected studies were assessed and subjected to data extraction and quality assessment using standard methods. Where appropriate, meta-analysis was carried out. A mathematical model was constructed to estimate the cost-effectiveness of vitamin K1. RESULTS: The electronic literature searches identified 1078 potentially relevant articles. Of these, 14 articles relating to five trials that compared vitamin K with a relevant comparator in postmenopausal women with osteoporosis or osteopenia met the review inclusion criteria. The double-blind ECKO trial compared 5 mg of phylloquinone (vitamin K1) with placebo in Canadian women with osteopenia but without osteoporosis. Four open-label trials used 45 mg of menatetrenone (vitamin K2) in Japanese women with osteoporosis; the comparators were no treatment, etidronate or calcium. The methodological quality of the ECKO trial was good; however, all four menatetrenone trials were poorly reported and three were very small (n < 100 in each group). Phylloquinone was associated with a statistically significant reduction in the risk of clinical fractures relative to placebo [relative risk 0.46, 95% confidence interval (CI) 0.22 to 0.99]; morphometric vertebral fractures were not reported. The smaller menatetrenone trials found that menatetrenone was associated with a reduced risk of morphometric vertebral fractures relative to no treatment or calcium; however, the larger Osteoporosis Fracture (OF) study found no evidence of a reduction in vertebral fracture risk. The three smaller trials found no significant difference between treatment groups in non-vertebral fracture incidence. In the ECKO trial, phylloquinone was not associated with an increase in adverse events. In the menatetrenone trials, adverse event reporting was generally poor; however, in the OF study, menatetrenone was associated with a significantly higher incidence of skin and skin appendage lesions. No published economic evaluations of vitamin K were found and a mathematical model was thus constructed to estimate the cost-effectiveness of vitamin K1. Comparators were alendronate, risedronate and strontium ranelate. Vitamin K1 and alendronate were markedly more cost-effective than either risedronate or strontium ranelate. The base-case results favoured vitamin K1, but this relied on many assumptions, particularly on the efficacy of preventing hip and vertebral fractures. Calculation of the expected value of sampled information was conducted assuming a randomised controlled trial of 5 years' duration comparing alendronate with vitamin K1. The costs incurred in obtaining updated efficacy data from a trial with 2000 women per arm were estimated to be a cost-effective use of resources. CONCLUSIONS: There is currently large uncertainty over whether vitamin K1 is more cost-effective than alendronate; further research is required. It is unlikely that the present prescribing policy (i.e. alendronate as first-line treatment) would be altered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There are insufficient data for hip fracture outcomes from trials of alphacalcidiol, 26 B 12 /folate, or vitamin K by other investigators, but vitamin K is reported to have no effect on bone density 29 or vertebral fracture risk.30”
From Systematic review and statistical analysis of the integrity of 33 randomized controlled trials (2016) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
1 retracted
Ishida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 132
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Professor Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090802 · Cited by 3,849
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Norman, A. W. (1979) · Cited by 3,769
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
(1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90218-e · Cited by 2,874
ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS
Alexeeva, L. P., Burkhardt, P., Christiansen, C., Cooper, C. C., Delmas, P. D., Johnell, O., Johnston, C. C., Kanis, J. A., Lips, P. T. A. M., Melton, L. J., et al. (1994) · Cited by 2,655
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Consensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Klotzbuecher, C. M., Ross, P. D., Landsman, P. B., Abbott, T. A., & Berger, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.721 · Cited by 2,023
Mortality after all major types of osteoporotic fracture in men and women: an observational study
Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N., & Eisman, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09075-8 · Cited by 1,926
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Evaluating patient-based outcome measures for use in clinical trials.
Fitzpatrick, Davey, Buxton, & Jones (1998) · Health Technology Assessment · doi:10.3310/hta2140 · Cited by 1,715
Meunier, P. J., Roux, C., Seeman, E., Ortolani, S., Badurski, J. E., Spector, T. D., Cannata, J., Balogh, A., Lemmel, E.-M., Pors-Nielsen, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa022436 · Cited by 1,638
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Qualitative research methods in health technology assessment: a review of the literature.
Murphy, Dingwall, Greatbatch, Parker, & Watson (1998) · Health Technology Assessment · doi:10.3310/hta2160 · Cited by 1,107
Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,102
Reginster, J. Y., Seeman, E., De Vernejoul, M. C., Adami, S., Compston, J., Phenekos, C., Devogelaer, J. P., Curiel, M. D., Sawicki, A., Goemaere, S., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1774 · Cited by 1,071
Variations in population health status: results from a United Kingdom national questionnaire survey
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998) · BMJ · doi:10.1136/bmj.316.7133.736 · Cited by 1,059
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041
Vertebral Fractures and Mortality in Older Women: A Prospective Study
Kado, D. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1215 · Cited by 1,039
Long-Term Risk of Osteoporotic Fracture in Malmö
Kanis, J. A., Johnell, O., Oden, A., Sernbo, I., Redlund-Johnell, I., Dawson, A., De Laet, C., & Jonsson, B. (2000) · Osteoporosis International · doi:10.1007/s001980070064 · Cited by 1,027
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M., Thompson, D. E., Bauer, D. C., Ensrud, K., Musliner, T., Hochberg, M. C., Nevitt, M. C., Suryawanshi, S., & Cummings, S. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6953 · Cited by 982
An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry
Kanis, J. A., & Glüer, C.-C. (2000) · Osteoporosis International · doi:10.1007/s001980050281 · Cited by 952
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Risk of Mortality Following Clinical Fractures
Cauley, J. A., Thompson, D. E., Ensrud, K. C., Scott, J. C., & Black, D. (2000) · Osteoporosis International · doi:10.1007/s001980070075 · Cited by 947
Storm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
Mortality and morbidity after hip fractures.
Keene, G. S., Parker, M. J., & Pryor, G. A. (1993) · BMJ · doi:10.1136/bmj.307.6914.1248 · Cited by 876
Quality-of-life measures in chronic diseases of childhood
Eiser, C., & Morse, R. (2001) · Health Technology Assessment · doi:10.3310/hta5040 · Cited by 872
Mortality after osteoporotic fractures
Johnell, O., Kanis, J. A., Odén, A., Sernbo, I., Redlund-Johnell, I., Petterson, C., De Laet, C., & Jönsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1490-4 · Cited by 848
The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds
Kanis, J. A., Oden, A., Johnell, O., Jonsson, B., de Laet, C., & Dawson, A. (2001) · Osteoporosis International · doi:10.1007/s001980170112 · Cited by 726
EFFECT OF RISEDRONATE ON THE RISK OF HIP FRACTURE IN ELDERLY WOMEN
Lung, R. M. C. C., Eusens, P. I. G., Aul, P., Iller, D. M., Ippel, H. A. Z., Ensen, W. I. G. B., Oux, C. H. R., Dami, S. I. A., Ogelman, I. G. F., Astell, R. I. E., et al. (2001) · Cited by 682
Indirect comparisons of competing interventions
Glenny, A., Altman, D., Song, F., Sakarovitch, C., Deeks, J., D'Amico, R., Bradburn, M., & Eastwood, A. (2005) · Health Technology Assessment · doi:10.3310/hta9260 · Cited by 677
Avenell, A., Gillespie, W. J., Gillespie, L. D., & O'Connell, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000227.pub3 · Cited by 667
Assessing the Quality of Randomized Trials
Clark, H. D., Wells, G. A., Huët, C., McAlister, F. A., Salmi, L. R., Fergusson, D., & Laupacis, A. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(99)00026-4 · Cited by 648
Smith, S., Lamping, D., Banerjee, S., Harwood, R., Foley, B., Smith, P., Cook, J., Murray, J., Prince, M., Levin, E., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9100 · Cited by 639
Epidemiology of fractures in 15 000 adults: The influence of age and gender
Singer, B. R., McLauchlan, G. J., Robinson, C. M., & Christie, J. H. (1998) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.80b2.7762 · Cited by 595
Pols, H. A. P., Felsenberg, D., Hanley, D. A., Štepán, J., Muñoz-Torres, M., Wilkin, T. J., Qin-sheng, G., Galich, A. M., Vandormael, K., Yates, A. J., et al. (1999) · Osteoporosis International · doi:10.1007/pl00004171 · Cited by 593
Brookes, S. T., Whitley, E., Peters, T. J., Mulheran, P. A., Egger, M., & Davey Smith, G. (2001) · Health Technology Assessment · doi:10.3310/hta5330 · Cited by 580
McCormack, K., Wake, B., Perez, J., Fraser, C., Cook, J., McIntosh, E., Vale, L., & Grant, A. (2005) · Health Technology Assessment · doi:10.3310/hta9140 · Cited by 578
Moher, D., Pham, B., Lawson, M., & Klassen, T. (2003) · Health Technology Assessment · doi:10.3310/hta7410 · Cited by 500
Vitamin K intake and hip fractures in women: a prospective study
Feskanich, D., Weber, P., Willett, W. C., Rockett, H., Booth, S. L., & Colditz, G. A. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.74 · Cited by 484
Does blinding of readers affect the results of meta-analyses?
Berlin, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62352-5 · Cited by 478
A systematic review of the role of bisphosphonates in metastatic disease
Ross, J., Saunders, Y., Edmonds, P., Patel, S., Wonderling, D., Normand, C., & Broadley, K. (2004) · Health Technology Assessment · doi:10.3310/hta8040 · Cited by 467
Schurgers, L. J., Teunissen, K. J. F., Hamulyák, K., Knapen, M. H. J., Vik, H., & Vermeer, C. (2007) · Blood · doi:10.1182/blood-2006-08-040709 · Cited by 423
Non-trauma mortality in elderly women with low bone mineral density
Browner, W. S., Seeley, D. G., Cummings, S. R., & Vogt, T. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)90489-c · Cited by 410
Shiraki, M., Shiraki, Y., Aoki, C., & Miura, M. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.3.515 · Cited by 408
Davis, Bamford, Wilson, Ramkalawan, Forshaw, & Wright (1997) · Health Technology Assessment · doi:10.3310/hta1100 · Cited by 407
Booth, S. L., Tucker, K. L., Chen, H., Hannan, M. T., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Ordovas, J., Schaefer, E. J., Dawson-Hughes, B., et al. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1201 · Cited by 406
Brocklebank, D., Ram, F., Wright, J., Barry, P., Cates, C., Davies, L., Douglas, G., Muers, M., Smith, D., & White, J. (2001) · Health Technology Assessment · doi:10.3310/hta5260 · Cited by 401
Oliver, S., Clarke-Jones, L., Rees, R., Milne, R., Buchanan, P., Gabbay, J., Gyte, G., Oakley, A., & Stein, K. (2004) · Health Technology Assessment · doi:10.3310/hta8150 · Cited by 400
The rational clinical examination. Is this patient taking the treatment as prescribed?
Stephenson, B. J. (1993) · JAMA · doi:10.1001/jama.269.21.2779 · Cited by 387
Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials
Song, F., & Glenny, A.-M. (1998) · Journal of British Surgery · doi:10.1046/j.1365-2168.1998.00883.x · Cited by 372
Churchill, R., Hunot, V., Corney, R., Knapp, M., McGuire, H., Tylee, A., & Wessely, S. (2002) · Health Technology Assessment · doi:10.3310/hta5350 · Cited by 368
Chesnut, C. H., McClung, M. R., Ensrud, K. E., Bell, N. H., Genant, H. K., Harris, S. T., Singer, F. R., Stock, J. L., Yood, R. A., Delmas, P. D., et al. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80134-x · Cited by 365
Kaltenthaler, E., Brazier, J., De Nigris, E., Tumur, I., Ferriter, M., Beverley, C., Parry, G., Rooney, G., & Sutcliffe, P. (2006) · Health Technology Assessment · doi:10.3310/hta10330 · Cited by 357
Statistical assessment of the learning curves of health technologies
Ramsay, C. R., Grant, A. M., Wallace, S. A., Garthwaite, P. H., Monk, A. F., & Russell, I. T. (2001) · Health Technology Assessment · doi:10.3310/hta5120 · Cited by 353
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
Mellström, D. D., Sörensen, O. H., Goemaere, S., Roux, C., Johnson, T. D., & Chines, A. A. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0286-7 · Cited by 350
Dietary Intake and Adequacy of Vitamin K
Booth, S. L., & Suttie, J. W. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.5.785 · Cited by 347
Meunier, P. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2060 · Cited by 337
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1
Tonino, R. P., Meunier, P. J., Emkey, R., Rodriguez-Portales, J. A., Menkes, C.-J., Wasnich, R. D., Bone, H. G., Santora, A. C., Wu, M., Desai, R., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6777 · Cited by 335
Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas, Jordan, Fry-Smith, Burls, & Hyde (2000) · Health Technology Assessment · doi:10.3310/hta4270 · Cited by 330
Postmarketing Surveillance and Adverse Drug Reactions: Current Perspectives and Future Needs
Brewer, T., & Colditz, G. A. (1999) · JAMA · doi:10.1001/jama.281.9.824 · Cited by 327
Meads, C., Cnossen, J., Meher, S., Juarez-Garcia, A., ter Riet, G., Duley, L., Roberts, T., Mol, B., van der Post, J., Leeflang, M., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12060 · Cited by 323
Routine preoperative testing: a systematic review of the evidence.
Munro, Booth, & Nicholl (1997) · Health Technology Assessment · doi:10.3310/hta1120 · Cited by 322
Costs and quality of life associated with osteoporosis-related fractures in Sweden
Borgström, F., Zethraeus, N., Johnell, O., Lidgren, L., Ponzer, S., Svensson, O., Abdon, P., Ornstein, E., Lunsjö, K., Thorngren, K. G., et al. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0015-8 · Cited by 320
Hampson, S. E., Skinner, T. C., Hart, J., Storey, L., Gage, H., Foxcroft, D., Kimber, A., Shaw, K., & Walker, J. (2001) · Health Technology Assessment · doi:10.3310/hta5100 · Cited by 311
Methods for the analysis of quality-of-life and survival data in health technology assessment.
Billingham, Abrams, & Jones (1999) · Health Technology Assessment · doi:10.3310/hta3100 · Cited by 307
Roderick, P., Ferris, G., Wilson, K., Halls, H., Jackson, D., Collins, R., & Baigent, C. (2005) · Health Technology Assessment · doi:10.3310/hta9490 · Cited by 301
Garry, R., Fountain, J., Brown, J., Manca, A., Mason, S., Sculpher, M., Napp, V, Bridgman, S., Gray, J., & Lilford, R. (2004) · Health Technology Assessment · doi:10.3310/hta8260 · Cited by 300
Elkan, Kendrick, Hewitt, Robinson, Tolley, Blair, Dewey, Williams, & Brummell (2000) · Health Technology Assessment · doi:10.3310/hta4130 · Cited by 297
Wiggins, M., Oakley, A., Roberts, I., Turner, H., Rajan, L., Austerberry, H., Mujica, R., & Mugford, M. (2004) · Health Technology Assessment · doi:10.3310/hta8320 · Cited by 296
Bricker, L., Garcia, J., Henderson, J., Mugford, M., Neilson, J. P., Roberts, T. E., & Martin, M. A. (2000) · PubMed · Cited by 293
Excess mortality after hospitalisation for vertebral fracture
Kanis, J. A., Oden, A., Johnell, O., De Laet, C., & Jonsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1516-y · Cited by 290
Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis
Jiang, G., Eastell, R., Barrington, N. A., & Ferrar, L. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1626-1 · Cited by 278
Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density
Bone, H. G. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.720 · Cited by 277
Ensrud, K. E., Barrett-Connor, E. L., Schwartz, A., Santora, A. C., Bauer, D. C., Suryawanshi, S., Feldstein, A., Haskell, W. L., Hochberg, M. C., Torner, J. C., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040326 · Cited by 275
Association Between Vertebral Fracture and Increased Mortality in Osteoporotic Patients
Jalava, T., Sarna, S., Pylkkänen, L., Mawer, B., Kanis, J. A., Selby, P., Davies, M., Adams, J., Francis, R. M., Robinson, J., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1254 · Cited by 275
King, Sibbald, Ward, Bower, Lloyd, Gabbay, & Byford (2000) · Health Technology Assessment · doi:10.3310/hta4190 · Cited by 274
Kanis, J. A., & Pitt, F. A. (1992) · Bone · doi:10.1016/s8756-3282(09)80004-5 · Cited by 272
Wilby, J., Kainth, A., Hawkins, N., Epstein, D., McIntosh, H., McDaid, C., Mason, A., Golder, S., O'Meara, S., Sculpher, M., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9150 · Cited by 271
Treatments for spasticity and pain in multiple sclerosis: a systematic review
Beard, S., Hunn, A., & Wight, J. (2003) · Health Technology Assessment · doi:10.3310/hta7400 · Cited by 266
Reginster, J., Felsenberg, D., Boonen, S., Diez‐Perez, A., Rizzoli, R., Brandi, M., Spector, T. D., Brixen, K., Goemaere, S., Cormier, C., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23461 · Cited by 261
MacLeod, Grant, Donaldson, Khan, Campbell, Daly, Lawrence, Wallace, Vale, Cody, et al. (1998) · Health Technology Assessment · doi:10.3310/hta2050 · Cited by 254
Sorensen, O. H., Crawford, G. M., Mulder, H., Hosking, D. J., Gennari, C., Mellstrom, D., Pack, S., Wenderoth, D., Cooper, C., & Reginster, J.-Y. (2003) · Bone · doi:10.1016/s8756-3282(02)00946-8 · Cited by 254
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis
Knowles, R., Griebsch, I., Dezateux, C., Brown, J., Bull, C., & Wren, C. (2005) · Health Technology Assessment · doi:10.3310/hta9440 · Cited by 252
Kaneki, M., Hedges, S. J., Hosoi, T., Fujiwara, S., Lyons, A., Crean, S. J., Ishida, N., Nakagawa, M., Takechi, M., Sano, Y., et al. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00554-2 · Cited by 248
Beswick, A., Rees, K., Griebsch, I., Taylor, F., Burke, M., West, R., Victory, J., Brown, J., Taylor, R., & Ebrahim, S. (2004) · Health Technology Assessment · doi:10.3310/hta8410 · Cited by 248
Hobart, J., Riazi, A., Lamping, D., Fitzpatrick, R., & Thompson, A. (2004) · Health Technology Assessment · doi:10.3310/hta8090 · Cited by 245
Monitoring blood glucose control in diabetes mellitus: a systematic review.
Coster, Gulliford, Seed, Powrie, & Swaminathan (2000) · Health Technology Assessment · doi:10.3310/hta4120 · Cited by 245
Wallace, P., Barber, J., Clayton, W., Currell, R., Fleming, K., Garner, P., Haines, A., Harrison, R., Jacklin, P., Jarrett, C., et al. (2004) · Health Technology Assessment · doi:10.3310/hta8500 · Cited by 237
Determinants of Reduced Survival Following Hip Fractures in Men
Poór, G., Atkinson, E. J., O'Fallon, W. M., & Melton, L. J. (1995) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199510000-00028 · Cited by 236
Newborn screening for inborn errors of metabolism: a systematic review.
Seymour, Thomason, Chalmers, Addison, Bain, Cockburn, Littlejohns, Lord, & Wilcox (1997) · Health Technology Assessment · doi:10.3310/hta1110 · Cited by 234
Lewis, S., Davies, L., Jones, P., Barnes, T., Murray, R., Kerwin, R., Taylor, D., Hayhurst, K., Markwick, A., Lloyd, H., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10170 · Cited by 233
Knapen, M. H. J., Schurgers, L. J., & Vermeer, C. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0337-9 · Cited by 232
Cooper, B., Stone, S., Kibbler, C., Cookson, B., Roberts, J., Medley, G., Duckworth, G., Lai, R., & Ebrahim, S. (2003) · Health Technology Assessment · doi:10.3310/hta7390 · Cited by 230
Wright, M., Grieve, R., Roberts, J., Main, J., & Thomas, H. (2006) · Health Technology Assessment · doi:10.3310/hta10210 · Cited by 230
Treatment of established osteoporosis: a systematic review and cost-utility analysis
Kanis, J. A., Brazier, J. E., Stevenson, M., Calvert, N. W., & Lloyd Jones, M. (2002) · Health Technology Assessment · doi:10.3310/hta6290 · Cited by 229
Self-citationFalse-negative results in screening programmes: systematic review of impact and implications.
Petticrew, Sowden, Lister-Sharp, & Wright (2000) · Health Technology Assessment · doi:10.3310/hta4050 · Cited by 225
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
Tucci, J. R., Tonino, R. P., Emkey, R. D., Peverly, C. A., Kher, U., & Santora, A. C. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00282-3 · Cited by 220
A systematic review of discharge arrangements for older people
Parker, S. G., Peet, S. M., McPherson, A., Cannaby, A. M., Abrams, K., Baker, R., Wilson, A., Lindesay, J., Parker, G., & Jones, D. R. (2002) · Health Technology Assessment · doi:10.3310/hta6040 · Cited by 212
Home treatment for mental health problems: a systematic review
Burns, T., Knapp, M., Catty, J., Healey, A., Henderson, J., Watt, H., & Wright, C. (2001) · Health Technology Assessment · doi:10.3310/hta5150 · Cited by 211
Shepherd, J., Brodin, H., Cave, C., Waugh, N., Price, A., & Gabbay, J. (2004) · Health Technology Assessment · doi:10.3310/hta8390 · Cited by 211
Cheung, A. M., Tile, L., Lee, Y., Tomlinson, G., Hawker, G., Scher, J., Hu, H., Vieth, R., Thompson, L., Jamal, S., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050196 · Cited by 211
Chilcott, J., Lloyd Jones, M., Wight, J., Forman, K., Wray, J., Beverley, C., & Tappenden, P. (2003) · Health Technology Assessment · doi:10.3310/hta7040 · Cited by 210
Clar, C., Cummins, E., McIntyre, L., Thomas, S., Lamb, J., Bain, L., Jobanputra, P., & Waugh, N. (2005) · Health Technology Assessment · doi:10.3310/hta9470 · Cited by 210
Diagnostic criteria of primary osteoporosis
Orimo, H., Sugioka, Y., Fukunaga, M., Muto, Y., Hotokebuchi, T., Gorai, I., Nakamura, T., Kushida, K., Tanaka, H., Ikai, T., et al. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050038 · Cited by 209
Screening for gestational diabetes: a systematic review and economic evaluation
Scott, D. A., Loveman, E., McIntyre, L., & Waugh, N. (2002) · Health Technology Assessment · doi:10.3310/hta6110 · Cited by 203
Recognizing and reporting osteoporotic vertebral fractures
Grigoryan, M., Guermazi, A., Roemer, F. W., Delmas, P. D., & Genant, H. K. (2003) · European Spine Journal · doi:10.1007/s00586-003-0613-0 · Cited by 202
Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
Davies, Cronin, Gill, Greengross, Hickman, & Normand (2000) · Health Technology Assessment · doi:10.3310/hta4030 · Cited by 201
Fogelman, I., Ribot, C., Smith, R., Ethgen, D., Sod, E., & Reginster for the bmd-mn Study Grou, J.-Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6603 · Cited by 198
Greenhalgh, J., Knight, C., Hind, D., Beverley, C., & Walters, S. (2005) · Health Technology Assessment · doi:10.3310/hta9090 · Cited by 197
Nevitt, M. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.77 · Cited by 196
Woodroffe, R., Yao, G., Meads, C., Bayliss, S., Ready, A., Raftery, J., & Taylor, R. (2005) · Health Technology Assessment · doi:10.3310/hta9210 · Cited by 195
Royle, P., & Waugh, N. (2003) · Health Technology Assessment · doi:10.3310/hta7340 · Cited by 194
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
WATTS, N. B., HARRIS, S. T., GENANT, H. K., WASNICH, E. D., MILLER, P. D., JACKSON, R. D., LICATA, A. A., ROSS, P., WOODSON, G. G., YANOVER, M. J., et al. (1991) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199101000-00023 · Cited by 190
Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women1
Bone, H. G., Downs, R. W., Tucci, J. R., Harris, S. T., Weinstein, R. S., Licata, A. A., McClung, M. R., Kimmel, D. B., Gertz, B. J., Hale, E., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3682 · Cited by 189
'Early warning systems' for identifying new healthcare technologies.
Robert, Stevens, & Gabbay (1999) · Health Technology Assessment · doi:10.3310/hta3130 · Cited by 189
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Tonino, R. P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3109 · Cited by 188
Cody, J., Wyness, L., Wallace, S., Glazener, C., Kilonzo, M., Stearns, S., McCormack, K., Vale, L., & Grant, A. (2003) · Health Technology Assessment · doi:10.3310/hta7210 · Cited by 187
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4118 · Cited by 187
Vitamin K Nutrition and Osteoporosis
Binkley, N. C., & Suttie, J. W. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.7.1812 · Cited by 185
Identification of vertebral fractures: An update
Ferrar, L., Jiang, G., Adams, J., & Eastell, R. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1880-x · Cited by 185
Factors Associated with Mortality after Hip Fracture
Meyer, H. E., Tverdal, A., Falch, J. A., & Pedersen, J. I. (2000) · Osteoporosis International · doi:10.1007/s001980050285 · Cited by 183
Lindsay, R., Cosman, F., Lobo, R. A., Walsh, B. W., Harris, S. T., Reagan, J. E., Liss, C. L., Melton, M. E., & Byrnes, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5989 · Cited by 180
Strontium ranelate for preventing and treating postmenopausal osteoporosis
O'Donnell, S., Cranney, A., Wells, G., Adachi, J., & Reginster, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005326.pub3 · Cited by 179
Mowatt, G., Vale, L., Perez, J., Wyness, L., Fraser, C., MacLeod, A., Daly, C., & Stearns, S. C. (2003) · Health Technology Assessment · doi:10.3310/hta7020 · Cited by 179
Epps, H., Ginnelly, L., Utley, M., Southwood, T., Gallivan, S., Sculpher, M., & Woo, P. (2005) · Health Technology Assessment · doi:10.3310/hta9390 · Cited by 179
Shepherd, Waugh, & Hewitson (2000) · Health Technology Assessment · doi:10.3310/hta4330 · Cited by 175
Effect of food composition on vitamin K absorption in human volunteers
Gijsbers, B. L. M. G., Jie, K.-S. G., & Vermeer, C. (1996) · British Journal of Nutrition · doi:10.1079/bjn19960027 · Cited by 175
McCarthy, C., Mills, P., Pullen, R., Richardson, G., Hawkins, N., Roberts, C., Silman, A., & Oldham, J. (2004) · Health Technology Assessment · doi:10.3310/hta8460 · Cited by 172
Garside, R., Pitt, M., Somerville, M., Stein, K., Price, A., & Gilbert, N. (2006) · Health Technology Assessment · doi:10.3310/hta10080 · Cited by 170
Coronary artery stents: a rapid systematic review and economic evaluation
Hill, R., Bagust, A., Bakhai, A., Dickson, R., Dündar, Y., Haycox, A., Mujica Mota, R., Reaney, A., Roberts, D., Williamson, P., et al. (2004) · Health Technology Assessment · doi:10.3310/hta8350 · Cited by 169
Lifetime Risk of Hip Fractures is Underestimated
Oden, A., Dawson, A., Dere, W., Johnell, O., Jonsson, B., & Kanis, J. A. (1998) · Osteoporosis International · doi:10.1007/s001980050105 · Cited by 169
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use
Morgan, K., Dixon, S., Mathers, N., Thompson, J., & Tomeny, M. (2004) · Health Technology Assessment · doi:10.3310/hta8080 · Cited by 166
Costs and benefits of community postnatal support workers: a randomised controlled trial
Morrell, Spiby, Stewart, Walters, & Morgan (2000) · Health Technology Assessment · doi:10.3310/hta4060 · Cited by 166
The cost-effectiveness of alendronate in the management of osteoporosis
Kanis, J. А., Adams, J. E., Borgström, F., Cooper, C. C., Jönsson, B., Preedy, D., Selby, P. L., & Compston, J. E. (2007) · Bone · doi:10.1016/j.bone.2007.10.019 · Cited by 165
Bone Mineral Density Is a Predictor of Survival
Johansson, C., Black, D., Johnell, O., Odén, A., & Mellström, D. (1998) · Calcified Tissue International · doi:10.1007/s002239900513 · Cited by 164
The current hospital costs of treating hip fractures
Lawrence, T. M., White, C. T., Wenn, R., & Moran, C. G. (2005) · Injury · doi:10.1016/j.injury.2004.06.015 · Cited by 164
Riley, R. D., Burchill, S. A., Abrams, K. R., Heney, D., Lambert, P. C., Jones, D. R., Sutton, A. J., Young, B., Wailoo, A. J., & Lewis, I. J. (2003) · Health Technology Assessment · doi:10.3310/hta7050 · Cited by 163
Lewis, R., Whiting, P., ter Riet, G., O'Meara, S., & Glanville, J. (2001) · Health Technology Assessment · doi:10.3310/hta5140 · Cited by 163
Marshall, D. A., Johnell, O., & Wedel, H. (1996) · Maturitas · doi:10.1016/0378-5122(96)81789-0 · Cited by 162
Ward, S., Kaltenthaler, E., Cowan, J., & Brewer, N. (2003) · Health Technology Assessment · doi:10.3310/hta7320 · Cited by 162
Main, C., Bojke, L., Griffin, S., Norman, G., Barbieri, M., Mather, L., Stark, D., Palmer, S., & Riemsma, R. (2006) · Health Technology Assessment · doi:10.3310/hta10090 · Cited by 156
Liquid-based cytology in cervical screening: a rapid and systematic review.
Payne, Chilcott, & McGoogan (2000) · Health Technology Assessment · doi:10.3310/hta4180 · Cited by 153
The cost of osteoporotic fractures in the UK: projections for 2000–2020
Burge, R. T., Worley, D. J., Johansen, A., Bhattacharyya, S., & Bose, U. (2001) · Journal of Medical Economics · doi:10.3111/200104051062 · Cited by 153
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
Meads, Cummins, Jolly, Stevens, Burls, & Hyde (2000) · Health Technology Assessment · doi:10.3310/hta4230 · Cited by 152
Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis.
Zeuner, Ades, Karnon, Brown, Dezateux, & Anionwu (1999) · Health Technology Assessment · doi:10.3310/hta3110 · Cited by 152
Brown, T., Hooper, L., Elliott, R., Payne, K., Webb, R., Roberts, C., Rostom, A., & Symmons, D. (2006) · Health Technology Assessment · doi:10.3310/hta10380 · Cited by 152
The value of digital imaging in diabetic retinopathy
Sharp, P., Olson, J., Strachan, F., Hipwell, J., Ludbrook, A., O'Donnell, M., Wallace, S., Goatman, K., Grant, A., Waugh, N., et al. (2003) · Health Technology Assessment · doi:10.3310/hta7300 · Cited by 148
What is the true mortality of hip fractures?
Parker, M. J., & Anand, J. K. (1991) · Public Health · doi:10.1016/s0033-3506(05)80614-6 · Cited by 148
Beyond Deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health
Vermeer, C., Shearer, M. J., Zittermann, A., Bolton-Smith, C., Szulc, P., Hodges, S. J., Walter, P., Rambeck, W., St�cklin, E., & Weber, P. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0480-4 · Cited by 147
Adámi, S., Passeri, M., Ortolani, S., Broggini, M., Carratelli, L., Caruso, I., Gandolini, G., Gnessi, L., Laurenzi, M. W., Lombardi, A., et al. (1995) · Bone · doi:10.1016/s8756-3282(95)00262-6 · Cited by 147
Bryant, J., Cave, C., Mihaylova, B., Chase, D., McIntyre, L., Gerard, K., & Milne, R. (2002) · Health Technology Assessment · doi:10.3310/hta6180 · Cited by 145
Boland, A., Dundar, Y., Bagust, A., Haycox, A. R., Hill, R. A., Mujica-Mota, R. E., Walley, T., & Dickson, R. (2003) · Health Technology Assessment · doi:10.3310/hta7150 · Cited by 136
What role for statins? A review and economic model.
Ebrahim, Smith, D., McCabe, Payne, Pickin, Sheldon, Lampe, Sampson, Ward, & Wannamethee (1999) · Health Technology Assessment · doi:10.3310/hta3190 · Cited by 134
Issues in methodological research: perspectives from researchers and commissioners
Lilford, R. J., Richardson, A., Stevens, A., Fitzpatrick, R., Edwards, S., Rock, F., & Hutton, J. L. (2001) · Health Technology Assessment · doi:10.3310/hta5080 · Cited by 132
Brazier, J., Tumur, I., Holmes, M., Ferriter, M., Parry, G., Dent-Brown, K., & Paisley, S. (2006) · Health Technology Assessment · doi:10.3310/hta10350 · Cited by 132
Kinley, H., Czoski-Murray, C., George, S., McCabe, C., Primrose, J., Reilly, C., Wood, R., Nicolson, P., Healy, C., Read, S., et al. (2001) · Health Technology Assessment · doi:10.3310/hta5200 · Cited by 129
Castelnuovo, E., Stein, K., Pitt, M., Garside, R., & Payne, E. (2005) · Health Technology Assessment · doi:10.3310/hta9430 · Cited by 127
Dalziel, K., Round, A., Stein, K., Garside, R., & Price, A. (2004) · Health Technology Assessment · doi:10.3310/hta8280 · Cited by 127
Main, C., Palmer, S., Griffin, S., Jones, L., Orton, V, Sculpher, M., Henderson, R., Sudlow, C., Hawkins, N., & Riemsma, R. (2004) · Health Technology Assessment · doi:10.3310/hta8400 · Cited by 125
Greenspan, S. L., Schneider, D. L., McClung, M. R., Miller, P. D., Schnitzer, T. J., Bonin, R., Smith, M. E., DeLucca, P., Gormley, G. J., & Melton, M. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-10-200205210-00009 · Cited by 124
Roderick, P., Davies, R., Raftery, J., Crabbe, D., Pearce, R., Bhandari, P., & Patel, P. (2003) · Health Technology Assessment · doi:10.3310/hta7060 · Cited by 122
Fowler, C., McAllister, W., Plail, R., Karim, O., & Yang, Q. (2005) · Health Technology Assessment · doi:10.3310/hta9040 · Cited by 121
Systematic review of endoscopic ultrasound in gastro-oesophageal cancer.
Harris, Kelly, Berry, Hutton, Roderick, Cullingworth, Gathercole, O'Connor, Boyce, & Smith (1998) · Health Technology Assessment · doi:10.3310/hta2180 · Cited by 121
French, Cowan, Mansour, Morris, Procter, Hughes, Robinson, & Guillebaud (2000) · Health Technology Assessment · doi:10.3310/hta4070 · Cited by 120
Symmons, D., Tricker, K., Roberts, C., Davies, L., Dawes, P., & Scott, D. (2005) · Health Technology Assessment · doi:10.3310/hta9340 · Cited by 120
Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
Burls, A., Clark, W., Stewart, T., Preston, C., Bryan, S., Jefferson, T., & Fry-Smith, A. (2002) · Health Technology Assessment · doi:10.3310/hta6090 · Cited by 120
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
Clegg, Bryant, & Milne (2000) · Health Technology Assessment · doi:10.3310/hta4090 · Cited by 118
Ushiroyama, T., Ikeda, A., & Ueki, M. (2002) · Maturitas · doi:10.1016/s0378-5122(01)00275-4 · Cited by 116
Roderick, P., Nicholson, T., Armitage, A., Mehta, R., Mullee, M., Gerard, K., Drey, N., Feest, T., Greenwood, R., Lamping, D., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9240 · Cited by 114
Bridle, C., Palmer, S. C., Bagnall, A., Darbà, J., Duffy, S., Sculpher, M. J., & Riemsma, R. P. (2004) · Health Technology Assessment · doi:10.3310/hta8190 · Cited by 114
Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women
Bone, H. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.265 · Cited by 114
Garside, R., Stein, K., Castelnuovo, E., Pitt, M., Ashcroft, D., Dimmock, P., & Payne, L. (2005) · Health Technology Assessment · doi:10.3310/hta9290 · Cited by 112
The burden of hospitalised fractures in Sweden
Johnell, O., Kanis, J. А., Jönsson, B., Odén, A., Johansson, H., & Laet, C. E. D. H. D. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1686-2 · Cited by 112
Finfer, S. R. (2006) · Journal of the Japan Society of Blood Transfusion · doi:10.3925/jjtc1958.52.19 · Cited by 111
Hummel, S., Paisley, S., Morgan, A., Currie, E., & Brewer, N. (2003) · Health Technology Assessment · doi:10.3310/hta7330 · Cited by 111
Berry, E., Kelly, S., Westwood, M. E., Davies, L. M., Gough, M. J., Bamford, J. M., Meaney, J. F. M., Airey, C. M., Cullingworth, J., Barbieri, M., et al. (2002) · Health Technology Assessment · doi:10.3310/hta6070 · Cited by 111
Kwartz, A., Henson, D., Harper, R., Spencer, A., & McLeod, D. (2005) · Health Technology Assessment · doi:10.3310/hta9460 · Cited by 110
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
Rossini, M., Gatti, D., Zamberlan, N., Braga, V., Dorizzi, R. M., & Adámi, S. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091121 · Cited by 106
Sculpher, Petticrew, Kelland, Elliott, Holdright, & Buxton (1998) · Health Technology Assessment · doi:10.3310/hta2100 · Cited by 105
Iwamoto, J., Takeda, T., & Ichimura, S. (2000) · Journal of Orthopaedic Science · doi:10.1007/s007760070003 · Cited by 103
No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women
Rejnmark, L., Vestergaard, P., Charles, P., Hermann, A. P., Brot, C., Eiken, P., & Mosekilde, L. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0044-3 · Cited by 103
Main, C., Shepherd, J., Anderson, R., Rogers, G., Thompson-Coon, J., Liu, Z., Hartwell, D., Loveman, E., Green, C., Pitt, M., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12200 · Cited by 103
Stein, K., Dalziel, K., Walker, A., McIntyre, L., Jenkins, B., Horne, J., Royle, P., & Round, A. (2002) · Health Technology Assessment · doi:10.3310/hta6310 · Cited by 103
Stevenson, M., Oakley, J. E., & Chilcott, J. B. (2004) · Medical Decision Making · doi:10.1177/0272989x03261561 · Cited by 98
Self-citationWilson, B., Torrance, N., Mollison, J., Wordsworth, S., Gray, J., Haites, N., Grant, A., Campbell, M., Miedyzbrodzka, Z., Clarke, A., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9030 · Cited by 97
Willis, B., Barton, P., Pearmain, P., Bryan, S., & Hyde, C. (2005) · Health Technology Assessment · doi:10.3310/hta9130 · Cited by 93
Research works printed but not linked: 15
- Torgerson DJ, Dolan P. The cost of treating osteoporotic fractures in the United Kingdom female population -the author replies. Osteoporos Int 2000;11:551-2.
- Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delams P, et al. Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 2005;20:1185-94.
- Duggan P, Cashman KD, Flynn A, Bolton-Smith C, Kiely M. Phylloquinone (vitamin K-1) intakes and food sources in 18-year-old to 64-year-old Irish adults. Br J Nutr 2004;92:151-8.
- Compston JE. Boning up on vitamin K - commentary. Gut 2001;48:448.
- Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review [erratum appears in JAMA 2002;288:1720]. JAMA 2002;287:3116-26.
- Cambridge Laboratories. Menadiol diphosphate tablets 10mg. 2002. URL: http://emc.medicines.org.uk/.
- National Osteoporosis Foundation Working Group on Vertebral Fractures. Assessing vertebral fractures. J Bone Miner Res 1995;10:518-523.
- Genant HK, Jergas M. Assessment of prevalent and incident fractures in osteoporosis research. Osteoporos Int 2003;14:S43-S55.
- Cranney A, Tugwell P, Wells G, Guyatt G. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocr Rev 2002;23:497-507.
- Insull W, Troendle A, Silvers A, Dunne CW. Substantial non-compliance to dose and time prescriptions for medications treating hypercholesterolaemia. Atherosclerosis 1995;115:S93.
- Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993;269:2779-81.
- Howell N, Trotter R, Mottram DR, Rowe PH. Compliance with statins in primary care. Pharm J 2004;272:23-6.
- Cochrane Review Manager 4.2.7. Oxford: The Cochrane Collaboration; 2004. URL: http://ims. cochrane.org/revman/.
- Shiraki M. Vitamin K2 effects on the risk of fractures and on lumbar bone mineral density in osteoporosis -a randomized prospective open-label 3-year study. Osteoporos Int 2002;13:S160.
- Eisai Co. Ltd. Eisai announces the intermediate analysis of anti-osteoporosis treatment post-marketing research to investigate the benefits of menatetrenone as part of the Ministry of Health, Labour and Welfare's Pharmacoepidemiological Drug Review Program. 2005. URL: www.eisai.co.jp/enews/.
Cited by
Fihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000095 · Cited by 1,029
Gribble, P. A., Bleakley, C. M., Caulfield, B. M., Docherty, C. L., Fourchet, F., Fong, D. T.-P., Hertel, J., Hiller, C. E., Kaminski, T. W., McKeon, P. O., et al. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096189 · Cited by 690
Doherty, C., Bleakley, C., Delahunt, E., & Holden, S. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096178 · Cited by 408
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
Tan, D. H. S., Hull, M. W., Yoong, D., Tremblay, C., O’Byrne, P., Thomas, R., Kille, J., Baril, J.-G., Cox, J., Giguere, P., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170494 · Cited by 220
O'Doherty, L. J., Taft, A., Hegarty, K., Ramsay, J., Davidson, L. L., & Feder, G. (2014) · BMJ · doi:10.1136/bmj.g2913 · Cited by 202
Metadata
- Authors
- Stevenson, M., Lloyd-Jones, M., & Papaioannou, D.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Stevenson, M
- Venue
- Health Technology Assessment
- Published
- 2009-09
- Volume
- 13
- Issue
- 45
- Pages
- iii-xi, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2158674987
- Cited by
- 90
- References
- 275
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 15 · 2015: 6 · 2014: 18 · 2013: 8 · 2012: 9
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Health Technology Assessment (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health Technology Assessment programme (07/16/01)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- vitamin K, osteoporotic fractures, postmenopausal women, vitamin K1, menatetrenone, fracture prevention, cost-effectiveness, vertebral fractures, non-vertebral fractures, osteopenia, osteoporosis, adverse events, economic evaluation model
- MeSH terms
- Aged, Aged, 80 and over, Cost-Benefit Analysis, Female, Humans, Vitamin K 1, Vitamin K, Vitamins, Osteoporosis, Postmenopausal, Models, Econometric, Quality-Adjusted Life Years, Vitamin K 2, Bone Density Conservation Agents, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.